PhotoMedex, Inc. (NASDAQ: PHMD) provides novel solutions designed for application in the areas of dermatology, therapeutic skin care and surgical products & services. The company is currently developing proprietary excimer laser and fiber-optic systems to treat dermatological applications such as psoriasis and vitiligo. PhotoMedex’s XTRAC® was the first FDA market-cleared excimer laser system designed to treat dermatological applications such as psoriasis and vitiligo. For further information, visit the Company’s web site at www.photomedex.com.
- 18 years ago
QualityStocks
PhotoMedex, Inc. (NASDAQ: PHMD)
Tags Rodman & Renshaw
Related Post
-
Mobilicom Ltd. (NASDAQ: MOB) Builds on $2.2 Million in Orders with Pipeline of Nine Tier-1 Design Wins Globally
Late last year, the Pentagon launched a $1 billion drone dominance program, with U.S. Secretary…
-
Gold Prices Rebound with Democratic Midterm Sweep In US
Disseminated on behalf of LaFleur Minerals Inc. and may include paid advertising. LaFleur Minerals Inc.…
-
Barry Ritholtz Joins Howard Lindzon to Open the Stocktoberfest 2026 Programming Day
The programming day of Stocktoberfest presented by Tradr ETFs opened on October 7 at City…